S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
Log in
LON:ABZA

Abzena plc (ABZA.L) Share Forecast, Price & News

GBX 15.75
0.00 (0.00 %)
(As of 10/11/2018)
Add
Compare
Today's Range
15.75
Now: GBX 15.75
15.75
50-Day Range
15.75
MA: GBX 15.75
15.75
52-Week Range
6
Now: GBX 15.75
33.70
Volume100 shs
Average Volume220,500 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Abzena plc provides services and technologies for the selection, development, and manufacture of biopharmaceutical products in North America, Europe, and internationally. Its technologies include antibody drug conjugate (ADC) linker, antibody humanization, and protein deimmunisation. It provides phage display, Hybridoma sequencing, and developability assessment solutions for the discovery, isolation, development, and selection of antibodies; immunogenicity assessment and custom assays, as well as Cytokine Screen, an in vitro assay to evaluate the risk of biopharmaceutical products causing cytokine storm prior to it being progressed into clinical development. It also offers antibody and protein engineering solutions, which cover Ig class and isotype switching, antibody reformatting and humanization, protein deimmunisation, affinity maturation, antibody and protein production, and bioassays and bioanalytics; and ADCs, such as cysteine and lysine conjugation solutions, as well as ThioBridge, a disulfide rebridging conjugation technology. In addition, it provides solutions in the area of bioassays, which cover drug-conjugate and payload characterization, binding and competition assays, cell health assays, functional assays, Fc binding and function assays, and bespoke assay development; bioanalytics that cover candidate selection, biosimilarity, protein and peptide identification, ADC characterization, and analytical method development; peptide synthesis, modifications, and analytics; mammalian manufacturing, which cover cell line, process, and analytical development, as well as cell banking; peptide synthesis, modifications, and analytics; bioconjugates and ADCs manufacturing; and custom, library, HPAPI, and payload synthesis. Further, it offers full-time equivalent and protein/BioNMR services; and analytical solutions. It serves biopharmaceutical companies and academic groups. Abzena plc was incorporated in 2014 and is headquartered in Cambridge, the United Kingdom.
Abzena plc (ABZA.L) logo

MarketRank

Overall MarketRank

0.58 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1223-903498
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
GBX 15.75
0.00 (0.00 %)
(As of 10/11/2018)
30 days | 90 days | 365 days | Advanced Chart

Receive ABZA News and Ratings via Email

Sign-up to receive the latest news and ratings for ABZA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Abzena plc (ABZA.L) (LON:ABZA) Frequently Asked Questions

What stocks does MarketBeat like better than Abzena plc (ABZA.L)?

Wall Street analysts have given Abzena plc (ABZA.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Abzena plc (ABZA.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Abzena plc (ABZA.L)'s key competitors?

What other stocks do shareholders of Abzena plc (ABZA.L) own?

Who are Abzena plc (ABZA.L)'s key executives?

Abzena plc (ABZA.L)'s management team includes the following people:
  • Dr. William John Edward Burt, CEO & Exec. Director (Age 50)
  • Prof. Sunil Shaunak, Co-Founder & Chairman of the Scientific Advisory Board
  • Dr. Antony Godwin Ph.D., Co-Founder
  • Prof. Steve Brocchini Ph.D., Co-Founder
  • Dr. Jim Mills, Sr. VP of Technical Operations

What is Abzena plc (ABZA.L)'s stock symbol?

Abzena plc (ABZA.L) trades on the London Stock Exchange (LON) under the ticker symbol "ABZA."

How do I buy shares of Abzena plc (ABZA.L)?

Shares of ABZA and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Abzena plc (ABZA.L)'s stock price today?

One share of ABZA stock can currently be purchased for approximately GBX 15.75.

What is Abzena plc (ABZA.L)'s official website?

The official website for Abzena plc (ABZA.L) is www.abzena.com.

How can I contact Abzena plc (ABZA.L)?

Abzena plc (ABZA.L)'s mailing address is Babraham Hall, Babraham Research, CAMBRIDGE, CB22 3AT, United Kingdom. The company can be reached via phone at +44-1223-903498.

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.